Pediatric Brain Tumor Clinical Trials

Clinical trials for pediatric oncology patients provide access to new, cutting-edge care that is not offered as part of standard of care at this time. For children especially, participating in clinical trials is a more common practice than participation for adults.  

Because of the research done during clinical trials, children are beating cancer at higher numbers than they were 20 years ago. And breakthroughs and discoveries continue through this approach to treatment.  

Siteman Kids patients have access to clinical trials that are taking place at multiple cancer centers across the country. Additionally, many of the WashU Medicine physicians caring for our pediatric oncology patients are also physician scientists, creating and leading these trials both nationwide and exclusively at Siteman Kids. These physicians lead both clinical trials and research studies to advance our understanding of how pediatric cancers develop and grow in order to find specific cures. This dedication to research and the close collaborative relationship with WashU’s medical school means that Siteman Kids patients have access to:  

  • Early Phase clinical trials led by WashU Medicine physicians 
  • Pediatric Early Phase-Clinical Trial Network (PEP-CTN), (Siteman Kids is 1 of 21 other member cancer centers) 
  • Children’s Oncology Group (COG), offering 100 trials a year 
  • Pediatric Neuro-Oncology Consortium (PNOC) clinical trials 
  • COllaborative Network for NEuro-oncology Clinical Trials (CONNECT) clinical trials
  • Project Sunshine clinical trials

Explore Clinical Trials

When you meet with your child’s care team, mention your interest in clinical trials if it hasn’t come up already. Then you and your team can discuss the benefits of them, and any questions you may have. If your child’s physician feels a clinical trial may be helpful to your child’s treatment plan, they will discuss it with you. And if they decide enrollment in a trial is not working well, they can make a change to something that is.